Skip to main content
. Author manuscript; available in PMC: 2018 May 9.
Published in final edited form as: Vaccine. 2017 Apr 11;35(20):2617–2621. doi: 10.1016/j.vaccine.2017.03.073

Figure 1. Serum antibodies in RSV-infected mice.

Figure 1

Nude mice were infected with RSV and 14 days later received no cells, splenocytes from RSV-primed BALB/c mice enriched for CD4+ T cells (depleted of CD8+ and MHC class II+ cells including B cells, monocytes, macrophages, and dendritic cells [‘CD4s’]), or the same splenocytes additionally depleted of CD4+ T cells (‘Depleted CD4s’). Antibody responses against RSV or a purified RSV fusion protein (F) were analyzed by ELISAs 5 weeks after RSV infections.